Jul 22, 2017 · 1 min read
The New York Times on 2017/07/17 reports on LSD, Psilocybin, and MDMA research, highlighting MAPS’ clinical trials of MDMA-assisted Psychotherapy for PTSD and LSD-assisted psychotherapy for anxiety associated with life-threatening illness.
